Unibest
← Back to patent-cliff list

Leflunomide

Tier C — Watch / trade

Leflunomide

Sanofi
Originator
1998
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:DHODH

Brand:Arava, Repso

Indications (approved):Rheumatoid arthritis, 狼疮肾炎, Psoriatic arthritis

Regional status

US
Approved
1998-09-10
EU
Approved
1999-09-02
China
Approved
2000-01-01
Japan
Approved
2003-04-16

Synthetic routes & intermediates6 routes

Originator routes × 1Optimised (non-patent) × 5Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 1 · Total yield 12.8 g
LEFU-00167305-24-2LEFU-002455-14-1API · Leflunomide
CodeCAS No.Intermediate
LEFU-00167305-24-25-methylisoxazole-4-carbonyl chloride
LEFU-002455-14-14-(trifluoromethyl)aniline
OptimisedRoute 2Steps 2 · Total yield 14.8 g
LEFU-003351-87-1LEFU-0041244971-54-7API · Leflunomide
CodeCAS No.Intermediate
LEFU-003351-87-13-oxo-N-(4-(trifluoromethyl)phenyl)butanamide
LEFU-0041244971-54-7(E)-2-((dimethylamino)methylene)-3-oxo-N-(4-(trifluoromethyl)phenyl)butanamide
OptimisedRoute 3Steps 1 · Total yield 24.4 g
LEFU-00167305-24-2LEFU-002455-14-1API · Leflunomide
CodeCAS No.Intermediate
LEFU-00167305-24-25-methylisoxazole-4-carbonyl chloride
LEFU-002455-14-14-(trifluoromethyl)aniline
OptimisedRoute 4Steps 1 · Total yield /
LEFU-002455-14-1LEFU-005—API · Leflunomide
CodeCAS No.Intermediate
LEFU-002455-14-14-(trifluoromethyl)aniline
LEFU-005-(ethyl carbonic) 5-methylisoxazole-4-carboxylic anhydride
OptimisedRoute 5Steps 1 · Total yield /
LEFU-002455-14-1LEFU-00667305-26-4API · Leflunomide
CodeCAS No.Intermediate
LEFU-002455-14-14-(trifluoromethyl)aniline
LEFU-00667305-26-4(benzyl carbonic) 5-methylisoxazole-4-carboxylic anhydride
OptimisedRoute 6Steps 1 · Total yield /
LEFU-002455-14-1LEFU-00767305-25-3API · Leflunomide
CodeCAS No.Intermediate
LEFU-002455-14-14-(trifluoromethyl)aniline
LEFU-00767305-25-32,4-dichlorophenyl 5-methylisoxazole-4-carboxylate

Frequently asked questions

What are the approved indications of Leflunomide?

Approved indications include: Rheumatoid arthritis, 狼疮肾炎, Psoriatic arthritis.

When does the Leflunomide patent expire?

No public expiry year is available for Leflunomide yet; this page updates once verified.

How many synthesis routes are recorded for Leflunomide?

6 synthesis routes are recorded; the shortest is 1 steps with 12.8 g total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Leflunomide intermediates?

All intermediates in Leflunomide routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Leflunomide intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-29